Merck & Co (NYSE: MRK)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $79.18
-
Support levelN/A
-
Resistance level$85.69
-
Beta0.3
-
RSI (14-day)25.8
- MRK is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- With a -37.5 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- MRK is one of this month's worst performers with a return of -16.3 percent, underperforming 90 percent of stocks in the S&P-100.
- Down 2.8 percent, MRK is one of this week's biggest decliners.
- Volatility is forecast to fall over the next month.
- With RSI < 30, MRK is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$77.55 | $132.96 | 3.9% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$104.64 | $89.36 | $87.33 | $83.01 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week10.2%
-
In the next month17.3%
-
In the next year49.0%
Period | Value |
---|---|
Historical (5 year) | 24.3% |
Last month | 23.4% |
Current estimate | 37.6% |
Next month forecast | 30.6% |